Drugs / plevitrexed
plevitrexed
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00014690 | Mar 2001 → Feb 2004 | fallopian tube cancer, ovarian cancer, primary peritoneal carcinoma | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | plevitrexed | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00014690 ↗ |
| Known as | Bgc-9331 | ChEMBL registry synonym — accepted as the source's own label CHEMBL126648 ↗ |
| Known as | NSC-696259 | ChEMBL registry synonym — accepted as the source's own label CHEMBL126648 ↗ |
| Known as | ZD-9331 | ChEMBL registry synonym — accepted as the source's own label CHEMBL126648 ↗ |
| Modality | Small molecule | — CHEMBL126648 ↗ |